Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)
CzechiaStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
BelgiumStudy on the Effects of Deucravacitinib for Adults with Inflammatory Skin Conditions (Epidermolysis Bullosa Simplex and Congenital Ichthyoses)
FranceStudy of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms
GreeceStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
AustriaStudy on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis
BelgiumStudy on the Effectiveness and Safety of Difelikefalin for Adults with Moderate-to-Severe Itching from Notalgia Paresthetica
GermanyStudy on Tirbanibulin for Treating Superficial Basal Cell Carcinoma in Patients
FranceStudy on the Safety and Effects of STAR-0215 for Adults with Hereditary Angioedema
BulgariaStudy on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus
DenmarkStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis
CzechiaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
